128 related articles for article (PubMed ID: 6184945)
1. Evidence for a selective inhibition by FLA 336(+) of the monoamine oxidase in serotonergic neurones in the rat brain.
Ask AL; Fagervall I; Ross SB
Acta Pharmacol Toxicol (Copenh); 1982 Oct; 51(4):395-6. PubMed ID: 6184945
[No Abstract] [Full Text] [Related]
2. Selective inhibition of monoamine oxidase in monoaminergic neurons in the rat brain.
Ask AL; Fagervall I; Ross SB
Naunyn Schmiedebergs Arch Pharmacol; 1983 Sep; 324(2):79-87. PubMed ID: 6646243
[TBL] [Abstract][Full Text] [Related]
3. Effects of zimelidine on serotoninergic and noradrenergic neurons after repeated administration in the rat.
Ross SB; Hall H; Renyi AL; Westerlund D
Psychopharmacology (Berl); 1981; 72(3):219-25. PubMed ID: 6164072
[No Abstract] [Full Text] [Related]
4. Selective inhibition by amiflamine of monoamine oxidase type A in rat brain, liver and duodenum.
Ask AL
Naunyn Schmiedebergs Arch Pharmacol; 1984 Aug; 327(1):56-63. PubMed ID: 6493351
[TBL] [Abstract][Full Text] [Related]
5. Interaction of selective inhibitors of monoamine oxidase with pethidine in rabbits.
Jounela AJ; Mattila MJ; Knoll J
Biochem Pharmacol; 1977 Apr; 26(8):806-8. PubMed ID: 856214
[No Abstract] [Full Text] [Related]
6. Intra- and extraneuronal monoamine oxidase.
Fowler CJ; Magnusson O; Ross SB
Blood Vessels; 1984; 21(3):126-31. PubMed ID: 6202347
[TBL] [Abstract][Full Text] [Related]
7. Selective inhibition by 4,alpha-dimethyl-m-tyramine (H77/77) and 4-methyl-alpha-ethyl-m-tyramine (H75/12) of the monoamine oxidase within serotonergic and noradrenergic neurons in the rat brain.
Fagervall I; Kelder D; Ross SB
Naunyn Schmiedebergs Arch Pharmacol; 1988 Aug; 338(2):143-7. PubMed ID: 2460774
[TBL] [Abstract][Full Text] [Related]
8. Effects of acute and repeated administration of amiflamine on monoamine oxidase inhibition in the rat.
Ask AL; Fagervall I; Jonze M; Kelder D; Nygren R; Ross SB
Biochem Pharmacol; 1984 Sep; 33(18):2839-47. PubMed ID: 6477643
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of 5-hydroxytryptamine accumulation and deamination by substituted phenylalkylamines in hypothalamic synaptosomes from normal and reserpine-pretreated rats.
Ask AL; Ross SB
Naunyn Schmiedebergs Arch Pharmacol; 1987 Dec; 336(6):591-6. PubMed ID: 2965308
[TBL] [Abstract][Full Text] [Related]
10. (+)-4-Dimethylamino-2,alpha-dimethylphenethylamine (FLA 336(+)), a selective inhibitor of the A form of monoamine oxidase in the rat brain.
Ask AL; Högberg K; Schmidt L; Kiessling H; Ross SB
Biochem Pharmacol; 1982 Apr; 31(7):1401-6. PubMed ID: 7092929
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of monoamine oxidase in 5-hydroxytryptaminergic neurones by substituted p-aminophenylalkylamines.
Ask AL; Fagervall I; Florvall L; Ross SB; Ytterborn S
Br J Pharmacol; 1985 Jul; 85(3):683-90. PubMed ID: 3861206
[TBL] [Abstract][Full Text] [Related]
12. Maximal turnover number of the membranal serotonin carrier in rat brain synaptosomes in vitro.
Ross SB; Hall H
Acta Physiol Scand; 1983 Jun; 118(2):185-7. PubMed ID: 6194656
[No Abstract] [Full Text] [Related]
13. Selective inhibition of monoamine oxidase by p-aminosubstituted phenylalkylamines in catecholaminergic neurones.
Ask AL; Fagervall I; Florvall L; Ross SB; Ytterborn S
Neuropharmacology; 1986 Jan; 25(1):33-40. PubMed ID: 3005903
[TBL] [Abstract][Full Text] [Related]
14. Binding of a specific 5-HT uptake inhibitor, [3H]norzimelidine, to rat brain homogenates.
Hall H; Ross S; Ogren SO; Gawell L
Eur J Pharmacol; 1982 May; 80(2-3):281-2. PubMed ID: 7106185
[No Abstract] [Full Text] [Related]
15. Effects of 5,6-dihydroxytryptamine on the release, synthesis, and storage of serotonin: studies using rat brain synaptosomes.
Wolf WA; Bobik A
J Neurochem; 1988 Feb; 50(2):534-42. PubMed ID: 2447243
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of monoamine oxidase within monoaminergic neurons in the rat brain by (E)-beta-fluoromethylene-m-tyrosine (MDL 72394).
Fagervall I; Ross SB
J Neurochem; 1989 Feb; 52(2):467-71. PubMed ID: 2521360
[TBL] [Abstract][Full Text] [Related]
17. Effects of zimelidine and desipramine on serotonin and noradrenaline uptake mechanisms in relation to plasma concentrations and to therapeutic effects during treatment of depression.
Aberg-Wistedt A; Jostell KG; Ross SB; Westerlund D
Psychopharmacology (Berl); 1981; 74(4):297-305. PubMed ID: 6457309
[TBL] [Abstract][Full Text] [Related]
18. Two types of monoamine liberation by chlorinated aralkylamines.
Pletscher A; Da Prada M; Bartholini G; Burkard WP; Bruderer H
Life Sci; 1965 Dec; 4(23):2301-8. PubMed ID: 5880882
[No Abstract] [Full Text] [Related]
19. Inhibition of monoamine oxidase in monoaminergic neurones in the rat brain by irreversible inhibitors.
Fagervall I; Ross SB
Biochem Pharmacol; 1986 Apr; 35(8):1381-7. PubMed ID: 2870717
[TBL] [Abstract][Full Text] [Related]
20. Monoamine oxidase-inhibiting properties of SR 95191, a new pyridazine derivative, in the rat: evidence for selective and reversible inhibition of monoamine oxidase type A in vivo but not in vitro.
Kan JP; Steinberg R; Leclercq J; Worms P; Biziere K
J Neurochem; 1988 Apr; 50(4):1137-44. PubMed ID: 3346672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
